Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 2451-2460 Newer>

The Motley Fool October 25, 2005 Stephen D. Simpson	Unpaid Bills Bedevil Triad Doubtful accounts were up to 11.2% after excluding self-pay discounts, and the company raised its allowance for doubtful accounts for the remainder of the year. This is a key problem for hospital operators. Investors, take note.
The Motley Fool October 25, 2005 Stephen D. Simpson	LCA-Vision Sees Clearly Now Growing share in a growing market provides a one-two punch for earnings at the laser vision correction specialist. Investors may want to wait for a stumble before buying in.
The Motley Fool October 25, 2005 Jason Mac Gurn	Visualizing Value for Flamel Those interested in the long-term potential of this biotech's business should be searching for signs that its technological potential will evolve to provide value for shareholders.
The Motley Fool October 25, 2005 Brian Gorman	Albany Molecular's Mixed Bag The pharma's contract services side is improving, and Allegra royalties won't disappear. Even so, the company seems to be facing some tough times ahead. Investors, take note.
BusinessWeek October 31, 2005	Power to the Patient In building a medical Internet for all Americans, the national coordinator for health-care information technology in the Health & Human Services Dept. wants the industry to evolve bottom up, with choices in consumers' hands.
BusinessWeek October 24, 2005 Timothy J. Mullaney	Protecting Patients' Privacy President Bush's health-tech czar has a plan to ensure that health records stored on a national network don't fall into the wrong hands.
The Motley Fool October 24, 2005 Stephen D. Simpson	Merck Needs to Take Its Medicine It will be a long, long time before business at the pharmaceutical returns to business as usual. Turnarounds can pay off for patient investors.
The Motley Fool October 24, 2005 Stephen D. Simpson	Vytorin Lifts Schering-Plough While the pharma is now officially in a turnaround phase, the news may already be baked into the stock.
The Motley Fool October 21, 2005 Stephen D. Simpson	Is Wyeth Your Happy Pill? The pharma has crawled back from scandal, but growth prospects aren't looking so healthy. Investors should not be in a hurry to pay a premium for these shares today.
BusinessWeek October 31, 2005 Timothy J. Mullaney	This Man Wants To Heal Healthcare David Brailer's job is to sell Bush's plan for rewiring American medicine. If he can, it could save lives -- and hundreds of billions of dollars.
<Older 2451-2460 Newer> Return to current articles.